Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
12°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
878.31
+7.94 (+0.91%)
Official Closing Price
Updated: 7:00 PM EST, Feb 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
January 24, 2025
Via
The Motley Fool
Eli Lilly Shares Fall After GLP-1 Sales Miss Expectations. Is the Stock in Trouble?
January 23, 2025
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
My Top 5 Stocks to Buy in Early 2025
January 23, 2025
Via
The Motley Fool
5 Stocks On Sale: Values Or Traps?
January 22, 2025
Lots of stocks can look cheap, especially after a sell-off. They may even have a low price-to-earnings (P/E) ratio. But that doesn’t mean the stock is a “value”.
Via
Talk Markets
Topics
Stocks / Equities
Maxwell Biosciences Announces Appointment of José Antonio Alas to Its Board of Directors
January 22, 2025
Austin, Texas--(Newsfile Corp. - January 22, 2025) - Maxwell Biosciences ("Maxwell"), a pre-clinical drug platform company that develops Claromers™, ...
Via
Newsfile
Is Novo Nordisk Stock a Buy?
January 18, 2025
Via
The Motley Fool
How Is The Market Feeling About Eli Lilly?
January 17, 2025
Via
Benzinga
Eli Lilly's Options: A Look at What the Big Money is Thinking
January 16, 2025
Via
Benzinga
Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today
January 16, 2025
Via
Benzinga
Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play
January 22, 2025
GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions
Via
MarketBeat
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
January 22, 2025
An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
Via
Benzinga
Stock Of The Day: Lilly's Strong Support Level Signals Potential Rebound
January 21, 2025
Stock of the Day: Eli Lilly & Co. (LLY) is rebounding from Friday's sales disappointment, finding support at $722 and set for another uptrend.
Via
Benzinga
Healthcare And Biotech Stocks Lag The Market Again
January 20, 2025
Biotech stocks got little help from the JPM Conference despite some recovery to the general market.
Via
Talk Markets
Topics
Stocks / Equities
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
January 19, 2025
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX,...
Via
Benzinga
Should You Buy the Dip in Eli Lilly Stock Right Now?
January 19, 2025
Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4.
Via
The Motley Fool
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
January 19, 2025
Via
The Motley Fool
3 Unstoppable Stocks to Buy in 2025
January 18, 2025
Via
The Motley Fool
Eli Lilly Stock Tumbles on Slower-Than-Expected Weight Loss Drug Sales. Is This a Buying Opportunity?
January 18, 2025
Via
The Motley Fool
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.
Via
Benzinga
Topics
Government
Exposures
Political
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
January 17, 2025
Many stocks flashed buy signals as the major indexes rose to or above key levels.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Novo Nordisk Stock Tumbles As Ozempic Faces US Pricing Scrutiny, Semaglutide Trial Underwhelms: Retail Gets Anxious
January 17, 2025
Though negotiated prices won't take effect until 2027, the inclusion of semaglutide has raised concerns about Novo's revenue and potential ripple effects on Eli Lilly's rival drugs.
Via
Stocktwits
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value
January 17, 2025
Here are three low-priced stocks you can buy today that are positioned in sector that make them solid choices to double in 2025
Via
MarketBeat
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
January 17, 2025
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with unknowns.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
January 17, 2025
FDA approves Eli Lilly's Omvoh for Crohn's disease, showing strong Phase 3 results in clinical remission and intestinal healing over two years.
Via
Benzinga
Exposures
Product Safety
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
January 17, 2025
These companies lead their respective markets, making them must-haves for buy-and-hold dividend investors.
Via
The Motley Fool
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
January 17, 2025
Via
The Motley Fool
Topics
Government
Exposures
Political
9 of the 10 Largest Companies in the World Are Making Big Moves Into AI. Here's Why Investors Should Pay Attention.
January 16, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
My 10 Top Stocks to Buy to Start the New Year Off Right
January 16, 2025
Via
The Motley Fool
Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall
January 15, 2025
Eli Lilly forecasts $45 billion revenue for 2024, 32% higher than last year. Medicare changes and stocking issues impact the revised guidance.
Via
Benzinga
Eli Lilly: What's Left To Like? A Lot, Says One Analyst.
January 15, 2025
The company cut its fourth-quarter guidance by 5%. But there's still a lot happening for Lilly.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.